Navigation Links
Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer
Date:3/30/2009

ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Frederick, MD (PRWEB) March 30, 2009 -- ConsentSolutions, Inc., a provider of electronic informed consent software for clinical research trials has named Jovianna DiCarlo President & Chief Executive Officer. Jovianna DiCarlo brings over 20 years experience driving new pharmaceutical therapeutics and devices through the entire development process from conceptualization, feasibility assessment, through clinical development to commercialization.

Ms. DiCarlo most recently served as the Dermatology Clinical Development Manager for NitricBio Therapeutics, Inc., an early stage biotechnology company where she led dermatology product development, and topical infectious disease drug/device development, and clinical trial programs all of which she managed through the identification and implementation of a customized platform of electronic clinical trial management applications.

Additionally, Ms. DiCarlo has utilized her extensive operational technology & regulatory expertise to combine intelligent electronic technology systems integration to develop and map operational and workflow processes to successfully support the launch several full service eCRO's, eIRB's, eSMO's, eResearch consortiums, and dedicated clinical research sites.

"I am passionate about actively contributing clinical research and development initiatives through the development, integration, adoption and implementation of intelligent technology applications to efficiently support clinical operations, and clinical research & development initiatives," said DiCarlo.

"My experience in deploying efficient real-time electronic applications to manage clinical trials leads me to believe that both industry and regulatory authorities will embrace the adoption and use of electronic clinical trial informed consenting practices."

We are pleased that Ms DiCarlo has joined us, says Susan Brink, DrPH, Chairman of the Board. Her track successful track record of applying technology solutions to support clinical trials, along with her business development acumen, EDC/CTMS, IRB, subject recruitment organizations, and CRO industry contacts position her to well to form technology business to business partnerships that will create added value for ConsentSolutions, Inc.

About ConsentSolutions, Inc
Founded in 2005, headquartered in Frederick, Maryland, with offices in Gaithersburg, ConsentSolutions is focused on adding value to the consenting process through the development of interactive, user-friendly educational software to effectively deliver clinical trial information electronically allowing study candidates to make important decisions about clinical trial participation. With decades of combined experience developing educational multimedia applications, ConsentSolutions, Inc. senior management team is dedicated to the goal of shared decision making for trial participation among study candidates, clinical trial coordinators, investigators, and physicians.

For more information contact:

Jovianna DiCarlo, President & CEO
jdicarlo (at) consentsolutions (dot) com
240-575-1918 Ext. 261
267.884.3456
www.consentsolutions.com

# # #

Read the full story at http://www.prweb.com/releases/2009/03/prweb2270884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine Notable People in R&D
2. US Oncology Named to FORTUNE Magazines Most Admired Companies List for Third Time
3. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
4. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
5. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
6. Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
7. Neogen Named Supplier of Chr. Hansen Probiotics for Swine and Poultry
8. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
9. Kendle Named a Best Place to Work in Greater Cincinnati
10. Sinovac Named to Deloitte Technology Fast 50 China
11. AMERIGROUP Corporation Named One of Best Places to Work in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... Calif. (PRWEB) , ... February 24, 2017 , ... Chef ... and wine scene. Making stops in several cities, she gained a number of ... adventure began in Stellenbosch, a town in South Africa’s Western Cape province. It ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):